Company has posted a profit of Rs 7.13 cr in Jun 30, 2024 quarter after 3 consecutive quarter of losses. (Source: Standalone Financials)
Bajaj Healthcare Share Price
Bajaj Healthcare Share ...
Bajaj Healthcare share price insights
Stock gave a 3 year return of -9.69% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company has spent 6.27% of its operating revenues towards interest expenses and 9.26% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Stock generated -9.69% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Bajaj Healthcare Ltd. share price moved down by -0.08% from its previous close of Rs 389.45. Bajaj Healthcare Ltd. stock last traded price is 389.15
Share Price Value Today/Current/Last 389.15 Previous Day 389.45
Key Metrics
PE Ratio (x) | -37.75 | ||||||||||
EPS - TTM (₹) | -10.31 | ||||||||||
MCap (₹ Cr.) | 1,073.99 | ||||||||||
Sectoral MCap Rank | 76 | ||||||||||
PB Ratio (x) | 3.86 | ||||||||||
Div Yield (%) | 0.26 | ||||||||||
Face Value (₹) | 5.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 389.94 | ||||||||||
52W H/L (₹) |
Bajaj Healthcare Share Price Returns
1 Day | -0.08% |
1 Week | -5.11% |
1 Month | 1.49% |
3 Months | 33.52% |
1 Year | 3.7% |
3 Years | N.A. |
5 Years | N.A. |
Bajaj Healthcare News & Analysis
NewsQ4 results today: NTPC, Hindalco among 257 companies to announce earnings on Friday
NewsFII vs DII on Dalal Street: Desi investor holding touches another all-time high
NewsBajaj Healthcare jumps 8% after USFDA inspection of Vadodara API plant
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcements
Bajaj Healthcare Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Bajaj Healthcare Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
PAT: Entering the Green
Company has posted a profit of Rs 7.13 cr in Jun 30, 2024 quarter after 3 consecutive quarter of losses. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 6.27% of its operating revenues towards interest expenses and 9.26% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 133.10 140.35 109.37 102.43 129.95 Total Income Growth (%) -5.17 28.33 6.78 -21.18 -18.35 Total Expenses 114.47 169.49 96.39 88.92 114.30 Total Expenses Growth (%) -32.46 75.84 8.40 -22.20 -22.14 EBIT 18.63 -29.14 12.98 13.51 15.66 EBIT Growth (%) - -324.49 -3.91 -13.72 26.64 Profit after Tax (PAT) 7.13 -29.92 -2.20 -3.46 -48.21 PAT Growth (%) - - - - -1,442.04 EBIT Margin (%) 14.00 -20.76 11.87 13.19 12.05 Net Profit Margin (%) 5.36 -21.32 -2.01 -3.38 -37.10 Basic EPS (₹) 2.59 -10.84 -0.80 -1.25 -17.47 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 765.13 901.46 721.10 525.63 325.75 Total Assets Growth (%) -15.12 25.01 37.19 61.36 22.07 Total Liabilities 486.77 533.77 392.62 267.22 174.14 Total Liabilities Growth (%) -8.81 35.95 46.93 53.45 26.43 Total Equity 278.36 367.69 328.49 258.41 151.61 Total Equity Growth (%) -24.29 11.93 27.12 70.44 17.43 Current Ratio (x) 1.16 1.17 1.24 1.41 1.23 Total Debt to Equity (x) 1.19 1.13 0.78 0.65 0.64 Contingent Liabilities 0.00 15.97 15.12 15.35 8.07 All figures in Rs Cr, unless mentioned otherwise
Insights
Decrease in Cash from Investing
Company has used Rs 11.24 cr for investing activities which is an YoY decrease of 87.96%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 92.29 -22.32 0.69 43.56 20.57 Net Cash used in Investing Activities -11.24 -93.43 -74.80 -108.93 -27.56 Net Cash flow from Financing Activities -96.60 131.50 61.85 75.46 3.28 Net Cash Flow -15.55 15.75 -12.27 10.08 -3.70 Closing Cash & Cash Equivalent 2.17 17.72 1.97 14.24 4.16 Closing Cash & Cash Equivalent Growth (%) -87.73 797.28 -86.13 242.46 -47.10 Total Debt/ CFO (x) 3.60 -18.56 374.25 3.86 3.46 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) -30.10 11.70 21.73 32.16 20.08 Return on Capital Employed (%) 16.37 17.42 25.63 37.05 21.67 Return on Assets (%) -10.95 4.77 9.89 15.81 6.90 Interest Coverage Ratio (x) 2.86 4.74 9.50 15.32 6.03 Asset Turnover Ratio (x) 0.57 0.83 1.09 124.98 125.86 Price to Earnings (x) -9.63 19.57 13.18 7.83 12.63 Price to Book (x) 2.90 2.29 2.86 2.52 2.53 EV/EBITDA (x) 13.38 11.41 9.96 5.62 6.88 EBITDA Margin (%) 17.94 16.10 17.64 21.80 12.44
Bajaj Healthcare Peer Comparison
Bajaj Healthcare Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -9.69% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -9.69% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -9.69% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated -9.69% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
0.00
Amount Invested (in Cr.)
0.03%
% of AUM
-8.73
% Change (MoM basis)
MF Ownership as on 31 July 2024
Corporate Actions
Bajaj Healthcare Board Meeting/AGM
Bajaj Healthcare Dividends
- Others
Meeting Date Announced on Purpose Details Aug 14, 2024 Aug 08, 2024 Board Meeting Quarterly Results & ESOP Jul 10, 2024 Jul 05, 2024 Board Meeting Preferential issue of shares May 24, 2024 May 16, 2024 Board Meeting Audited Results & Final Dividend Feb 09, 2024 Feb 05, 2024 Board Meeting Quarterly Results Nov 09, 2023 Nov 03, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 20% 1.0 Sep 22, 2023 May 30, 2023 Final 30% 1.5 Sep 22, 2022 May 17, 2022 Special 5% 0.5 Sep 28, 2021 Jun 10, 2021 Final 5% 0.5 Sep 28, 2021 Jun 09, 2021 Final 20% 1.0 - May 24, 2024 All Types Ex-Date Record Date Announced on Details Splits Sep 28, 2021 Sep 29, 2021 Aug 13, 2021 Split: Old FV10.0| New FV:5.0 Bonus Apr 09, 2019 Apr 10, 2019 Feb 19, 2019 Bonus Ratio: 1 share(s) for every 1 shares held
About Bajaj Healthcare
Bajaj Healthcare Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 1,074.82 Crore) operating in Pharmaceuticals sector. Bajaj Healthcare Ltd. key Products/Revenue Segments include Pharmaceuticals and Sale of services for the year ending 31-Mar-2023. Show More
Executives
Auditors
- SR
Sajankumar R Bajaj
Chairman & Managing DirectorACAnil C Jain
Managing DirectorRHRupesh H Nikam
WholeTime Director & CFODSDhananjay S Halte
Whole Time DirectorShow More - Chaturvedi & AgrawalParesh Rakesh & Associates
Industry
Key Indices Listed on
BSE SmallCap, BSE Healthcare, BSE AllCap, + 1 more
Address
602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/A, B-39 A/1,Road No. 23,Thane, Maharashtra - 400604
More Details
Trending in Markets
Bajaj Healthcare Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.